4-5 pages due by 25 hours

4-5 pages due by 25 hours

4-5 pagesOutlineTrastuzumab Deruxtecan and Patient with HER2-Positive Breast Cancer1. Introduction: [Introduce Trastuzumab Deruxtecan and its role in contributing to HER2-Positive Breast Cancer, basic information of breast cancer, and explain why I aminterested in this topic or why it is important. (back up with epidemiologic data)2. Subheading 1 – Major advantages of Trastuzumab Deruxtecan: [Discuss the mainpharmacological issues]3. Subheading 2 – Major disadvantage of Trastuzumab Deruxtecan: Discusspharmacological issues) (I will look up for more biological data to back up mystatement).]4. Subheading 3 – Consideration on Trastuzumab Deruxtecan for HER2-positive breastcancer patients: [Discuss epidemiologic evidence, Discuss clinical use.5. Conclusion: [Final take-home messages, briefly summarize major findings of review onthe effects of Trastuzumab Deruxtecan and HER2-positive breast cancer.Tables: [Table summarizing the studies of the association between Trastuzumab Deruxtecan forHER2-positive breast cancer patients.